C5aR ANTAGONISTS
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/139,919, filed Dec 22, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,906,938 | C5aR ANTAGONISTS In force · High confidence | Chemocentryx, Inc. | In force | High confidence | ||
| US 9,126,939 | C5AR Antagonists In force · High confidence | Chemocentryx, Inc. | In force | High confidence | ||
| US 9,573,897 | C5AR Antagonists In force · High confidence | Chemocentryx, Inc. | In force | High confidence | ||
| US 10,035,768 | C5AR Antagonists In force · High confidence | Chemocentryx, Inc. | In force | High confidence | ||
| US 10,660,897 | C5aR ANTAGONISTS In force · High confidence | Chemocentryx, Inc. | In force | High confidence | ||
| US 8,445,515 | C5aR ANTAGONISTS In force · High confidence | Chemocentryx, Inc. | In force | High confidence | ||
| Application 12/823,039 | C5aR ANTAGONISTS Abandoned Abandoned Dec 19, 2012 | Chemocentryx, Inc. | Abandoned | Abandoned Dec 19, 2012 | ||
| Application 13/072,616 | C5aR ANTAGONISTS Abandoned Abandoned Jan 27, 2015 | Chemocentryx, Inc. | Abandoned | Abandoned Jan 27, 2015 | ||
| Application 14/531,385 | C5aR ANTAGONISTS Abandoned Abandoned Jan 22, 2017 | Chemocentryx, Inc. | Abandoned | Abandoned Jan 22, 2017 | ||
| Application 15/354,878 | C5aR ANTAGONISTS Abandoned Abandoned Aug 7, 2018 | Chemocentryx, Inc. | Abandoned | Abandoned Aug 7, 2018 | ||
| 7 more patents in this group · Pro | ||||||
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17.
6 of these are in force and held by Chemocentryx, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.